PhD Scientific Days 2021

PO_II_L: Pathology and Oncology II. Lectures

Distribution of Sunitinib, an Antiangiogenic Tyrosine Kinase Inhibitor, in Primary Versus Metastatic Tumors in Mice

Előadó neve

Ms. Anna, S-Tisza

Előadó munkahelye

1st Department of Pathology and Experimental Cancer Research, Semmelweis University

Előadó telefonszáma

06207739471

Előadó e-mail címe

solyomtisza.anna@gmail.com

Az előadás címe

Distribution of Sunitinib, an Antiangiogenic Tyrosine Kinase Inhibitor, in Primary Versus Metastatic Tumors in Mice

Szerző(k) neve és munkahelye

Anna S-Tisza1,2, Szilvia Török1, Áron Gellért1,5, Yutaka Sugihara3, Katalin Dezső2, Edina Bugyik1,2, Nándor Bárány1,2, József Tóvári6, Sándor Paku2, György Markó-Varga3, Melinda Rezeli3, Viktória László1,4, Balázs Döme1,4,5

1 Department of Tumor Biology, National Korányi Institute of Pulmonology, Budapest, Hungary
2 1st Department of Pathology and Experimental Cancer Research, Semmelweis University
3 Clinical Protein Science & Imaging, Dept. of Biomedical Engineering, Lund University, Sweden
4 Division of Thoracic Surgery, Department of Surgery, Comprehensive Cancer Center, Medical University of Vienna, Austria
5 Department of Thoracic Surgery, Semmelweis University and National Institute of Oncology, Budapest, Hungary
6 Department of Experimental Pharmacology, National Institute of Oncology, Budapest, Hungary

Bemutatás módja

Szóbeli

Szekció

Pathology and Oncology II. Lectures

Language of the presentation

English

Preferred session

Pathology and Oncology

Összefoglaló szövege

No consent for the publication for this abstract.

University and Doctoral School

Semmelweis University, Doctoral School of Pathological Sciences

Supervisor

Viktória László

Publication of my abstract

I do not give consent to the publication of my abstract on the website of the congress.

Kind

Szabad

Status

elfogadva

Accepted presentation method

szóbeli

Előadás fájl jóváhagyás

nem rendelkezett róla

Előadó

4684

Start

16:45

End

17:00

Authors (legacy)

Anna S-Tisza1,2, Szilvia Török1, Áron Gellért1,5, Yutaka Sugihara3, Katalin Dezső2, Edina Bugyik1,2, Nándor Bárány1,2, József Tóvári6, Sándor Paku2, György Markó-Varga3, Melinda Rezeli3, Viktória László1,4, Balázs Döme1,4,5

1 Department of Tumor Biology, National Korányi Institute of Pulmonology, Budapest, Hungary
2 1st Department of Pathology and Experimental Cancer Research, Semmelweis University
3 Clinical Protein Science & Imaging, Dept. of Biomedical Engineering, Lund University, Sweden
4 Division of Thoracic Surgery, Department of Surgery, Comprehensive Cancer Center, Medical University of Vienna, Austria
5 Department of Thoracic Surgery, Semmelweis University and National Institute of Oncology, Budapest, Hungary
6 Department of Experimental Pharmacology, National Institute of Oncology, Budapest, Hungary